Home › Funds › Trails Edge Capital Partners, LP › IRD

Trails Edge Capital Partners, LP position in IRD

OPUS GENETICS INC · Health Care

Trails Edge Capital Partners, LP reported holding 2,743,658 shares of IRD (OPUS GENETICS INC) in its Q2 2026 13F filing — a position valued at US$11.3M, representing 1.79% of its reported portfolio and ranking #22 among its reported holdings. Trails Edge Capital Partners, LP has disclosed IRD holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)2.74M sh
Reported value held$11.28M
Portfolio Weight1.79%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's IRD position evolved

Trails Edge Capital Partners, LP first disclosed a stake in IRD in Q1 2026 at 500,000 shares (US$2.3M). The position peaked in Q2 2026 at 2,743,658 shares, worth US$11.3M. Across 2 filings, Trails Edge Capital Partners, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,743,658 shares valued at US$11.3M — an increase of 2,243,658 shares quarter over quarter.. Notable position changes include a 449% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 500.00K $2.27M New
Q2 2026 2.74M $11.28M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IRD and 13F data

IRD (OPUS GENETICS INC) is a Health Care company. 68 other funds we track also report a position in IRD — the largest reported positions include Caligan Partners LP (US$25.0M), BIOS Capital Management, LP (US$15.1M), Boxer Capital Management, LLC (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IRD

All IRD fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held IRD?

Trails Edge Capital Partners, LP has disclosed IRD holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Trails Edge Capital Partners, LP's current position in IRD?

As of Q2 2026, Trails Edge Capital Partners, LP holds 2.74M shares of IRD (OPUS GENETICS INC), valued at $11.28M, representing 1.79% of its reported portfolio and ranking #22.

Has Trails Edge Capital Partners, LP been buying or selling IRD?

In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP increased its position in IRD. The position peaked in Q2 2026 at 2.74M shares.

Which other funds hold IRD?

Other major institutional holders of IRD include Caligan Partners LP, BIOS Capital Management, LP, Boxer Capital Management, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.